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Chronic cardiorespiratory disease is associated with low birthweight suggesting the importance of the
developmental environment. Prenatal factors affecting fetal growth are believed important, but the
underlying mechanisms are unknown. The influence of developmental programming on bronchial
hyperreactivity is investigated in an animal model and evidence for comparable associations is sought in
humans. Pregnant Wistar rats were fed either control or protein-restricted diets throughout pregnancy.
Bronchoconstrictor responses were recorded from offspring bronchial segments. Morphometric analysis of
paraffin-embedded lung sections was conducted. In a human mother-child cohort ultrasound
measurements of fetal growth were related to bronchial hyperreactivity, measured at age six years using
methacholine. Protein-restricted rats’ offspring demonstrated greater bronchoconstriction than controls.
Airway structure was not altered. Children with lesser abdominal circumference growth during 11–19
weeks’ gestation had greater bronchial hyperreactivity than those with more rapid abdominal growth.
Imbalanced maternal nutrition during pregnancy results in offspring bronchial hyperreactivity. Prenatal
environmental influences might play a comparable role in humans.
U
nder the ‘developmental origins of health and disease’ hypothesis physiological and anatomical changes
invoked by early environmental factors are able to influence later health. This is sometimes referred to as
‘programming’ or ‘developmental induction’1. Factors capable of invoking developmental induction
before birth include maternal diet2, body composition3 and endocrine status4. Epidemiological evidence suggests
that faltering fetal growth is associated with adverse respiratory outcomes. Following from early observations of
increased chronic obstructive pulmonary disease in adults who were of low birthweight5, studies linking faltering
fetal growth to wheeze in childhood have provided further evidence that early environmental factors can influ-
ence respiratory development6,7. These epidemiological observations do not provide information about under-
lying pathophysiological mechanisms; to understand these, animal models of fetal growth restriction are
required8. Moreover, these models should reflect that whilst the majority of of human infants in westernized
countries are of normal weight at birth, adverse consequences may occur as a result of growth faltering during a
critical window of development.
Animal data demonstrate thatmaternal protein restriction in rats results in hypertension in the offspring9. This
is linked to clinical evidence that aortic compliance is lower in adults born at low birthweight10 and that low
birthweight individuals have an increased likelihood in adulthood of cardiovascular disease, including hyper-
tension11. In part, the association between early growth restriction and hypertensionmay reflect adaptive changes
affecting vascular smooth muscle. Animal and epidemiological studies suggest that bronchial smooth muscle
might be similarly sensitive to environmental influences. Hyperreactivity of bronchial smooth muscle has been
demonstrated in individuals born at low birthweight (a surrogate for restricted fetal growth)12,13. Animal models
also show bronchial hyperreactivity (BHR) to be present inmice exposed to adverse environmental factors which
are likely to restrict fetal growth, for example maternal stress14. We hypothesize that an adverse in utero envir-
onment, in this case imbalanced nutrition, is associated with BHR in the offspring. The primary objective of the
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animal work included in this study was to investigate this using a
model which has already demonstrated a number of the cardiovascu-
lar risk factors associated with poor fetal growth (including hyper-
tension and endothelial dysfunction)15,16, Since Rho A has been
implicated in bronchial hyper-responsiveness in mouse models17,
rat models18 and humans19,20 a secondary objective was to use the
animal model to explore whether Rho A, and associated kinases
ROCK1 and ROCK2 may be sensitive to developmental stress and
hence serve as a link between adverse factors in the fetal environment
and later BHR. Finally, to test the relevance of factors affecting fetal
growth to human respiratory development, we analysed data from an
epidemiological cohort where both detailed prenatal ultrasound
measurements and childhood BHR measurements are available.
Results
Animal model. Birthweight and growth. There were no between
group differences in litter size or birthweight. This was true for
both male (C, 7.60 g 6 0.16, n 5 7; PR, 7.74 g 6 0.40, n 5 6; P .
0.05) and female (C, 7.41 g6 0.19, n5 7; PR, 7.46 g6 0.34, n 5 6; P
. 0.05) pups. Similarly growth of the offspring was not different
between the groups (data not shown) and there was no significant
difference between the rats at 75 days of age (C, 320.6 g; PR, 280.4 g;
p . 0.05).
Bronchoconstriction. In isolated bronchi from 35-day-old rats, both
CCh and U46619 produced a concentration-dependent constriction
that was similar between groups (p . 0.05; Figure 1). By 75 days of
age maximal response to both agonists was significantly increased in
the PR bronchi compared to controls (p , 0.001; Figure 2). In the
presence of the Rho kinase inhibitor Y27632, differences in response
to carbachol were abolished (Figure S1). Responses to the depolaris-
ing KPSS wash were similar between the groups at both time points
(data not shown).
RhoA, ROCK1 and ROCK2mRNA expression levels. In isolated bron-
chi from 75-day-old male offspring, mRNA levels of Rho A were
similar between the groups (C, 0.59 6 0.03, n 5 5; PR, 0.60 6
0.02, n 5 4; P . 0.05). Equally, mRNA levels of ROCK1 (C, 0.62
6 0.11, n 5 5; PR, 0.656 0.05, n 5 4; P. 0.05) and ROCK2 (C, 0.78
6 0.04, n 5 5; PR, 0.94 6 0.13, n 5 4; P . 0.05) were not different
between the two groups.
Morphometry. There was no between group difference in percentage
airway smooth muscle at day 225. Equally, no between group differ-
ences were seen for percentage of any other airway component
(lumen or epithelium), percentage parenchymal tissue or airspaces,
or vessel lumen. The volume fraction of vascular muscle was signifi-
cantly greater in the protein restricted group compared to control
(median 1.70 vs. 1.25, p 5 0.01) (Figures 3 and 4).
Fetal growth and BHR in childhood. Mothers and children
followed up to 6 years were broadly similar in terms of asthma,
Figure 1 | Cumulative addition of (A) CCh or (B) the thromboxanemimetic U46619 to isolated bronchi from 35 day oldmale offspring fromC (o, n5
6) or PR (N, n 5 5) dams.
Figure 2 | Cumulative addition of (A) CCh or (B) U46619 to isolated bronchi from 75 day old male offspring from C (o, n5 6) or PR (N, n5 4) dams.
*** indicates p , 0.001% max response C vs. PR.
www.nature.com/scientificreports
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atopy and allergic disorders to those who were not followed up.
Participant mothers were, however, of lower parity and were
slightly older, taller, less likely to smoke in pregnancy and were of
higher educational attainment than non-participants (Table S2). Of
the participating mother-child pairs, those who provided methacho-
line provocation challenge data had a significantly higher number of
siblings than those who did not complete a methacholine challenge
but were otherwise comparable (Table S3).Maternal smoking during
pregnancy was not found to be a confounder of the relationship
between fetal growth and BHR.
Methacholine provocation challenge.Higher inverse log values of the
dose response slope, (lower BHR), were significantly associated with
increasing conditional abdominal circumference growth between 11
and 19weeks’ gestation (p5 0.037). That is to say, greater faltering of
abdominal growth was associated with greater BHR. There were no
significant associations between birthweight and BHR.Moreover, no
association was found between abdominal circumference growth
between 19 and 34 weeks’ gestation, or birth head or abdominal
circumference and BHR (Table 1).
Discussion
This paper demonstrates, for the first time, BHR following maternal
dietary restriction in an animal model. This is supported by observa-
tions in a human population birth-cohort. In the offspring of pro-
tein-restricted rats, bronchoconstriction to both CCh and U46619
was significantly enhanced compared to control animals; this pheno-
type was not due to altered airway structure. We also demonstrated
an inverse association between abdominal circumference growth
between 11 and 19 weeks’ gestation and BHR measured in 6-year-
old children. These findings suggest that unfavourable in utero con-
ditions might adversely affect respiratory development and perhaps
predispose to subsequent respiratory disease.
This study shows that restricted fetal growth is associated with
BHR in both rats and humans. Our data also suggest that airway
smooth muscle changes may underlie this association. These are
novel animal model findings that are supported by the Southamp-
ton Women’s Survey, one of few epidemiological cohorts with
detailed longitudinal ultrasound scan measurements of fetal growth.
Reduced abdominal growth is recognized as an important fetal
adaptation to in utero adversity, which is believed to protect brain
growth27. Notably there was no association between infant birth-
weight and BHR in childhood; the association found between
reduced abdominal growth in early pregnancy and BHR shows sim-
ilarities to the findings in the animal model and suggests common
‘programming’ mechanisms, possibly mediated via subtly altered
fetal growth patterns acting in both animals and humans subjected
to developmental stress. The significant relationship between
abdominal circumference growth in early pregnancy and BHR
may reflect a period of particular importance in bronchial smooth
muscle development. Recently, Zaina-Taieb et al have used a very
similar protocol to ours in order to study the development of
bronchopulmonary dysplasia. Their study looked at early morpho-
metrywith differences in alveolarisation, whereas our study found no
difference at 28 or 225 d. Interestingly, Zana-Taieb et al showed
significant differences in birthweight, such that the protein restricted
group could be considered IUGR. Previous studies have also linked
IUGR to changes in lung structure whilst our study produced normal
sized offspring with hyper-reactive airways. It is not clear how their
protocol produced IUGR offspring whilst ours did not.
The significance of early growth restriction in relation to respir-
atory health has been appreciated since the report of associations
between infant weight and death in adulthood from respiratory dis-
ease5. Moreover, impaired lung function has been found in indivi-
duals who were of low birthweight28–30. Reduced forced expiratory
flows have been demonstrated in lower birthweight individuals
within a group of term babies of normal average birthweight; the
lowest lung function was found in infants who gained weight rapidly
after birth31. This pattern of growth may indicate mismatched pre-
and postnatal nutrient supply and thus identify infants subjected to
fetal growth restriction. Within the same cohort lower infant lung
function has been shown to be associated with wheezing illnesses in
early childhood32. Taken together with epidemiological evidence
showing lower birthweight to be associated with later respiratory
morbidity, including asthma33 and chronic obstructive pulmonary
disease5, this suggests lung function may be persistently impaired
Figure 3 | Comparison of airway wall histology in offspring of control and protein restricted mothers.
www.nature.com/scientificreports
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following fetal growth faltering and supports the concept of lung
function ‘tracking’ throughout life34.
An association between low birthweight and BHR has been recog-
nized for some time35 but studies addressing the effect of fetal growth
restriction upon this specific aspect of lung function have been con-
founded by the effects of respiratory complications of prematurity
and their treatment36,37. Although there is a wealth of evidence on low
birthweight and respiratory health38,39, there is a relative paucity of
data relating these outcomes to fetal growth within those who are not
classified as growth restricted. Offspring fromour animal study are of
normal birthweight but were exposed to nutrient stress during pre-
natal development, similarly our human data include infants whose
birth weights were within the normal range but whose growth, pos-
sibly due to adverse environmental influences, faltered during a crit-
ical developmental window. This may be highly relevant to
understanding the prenatal origins of respiratory disease in the
developed world where most children are born well grown but some
have suffered a stress during a critical developmental window. Four
studies have explored the relationship between ultrasound measures
of fetal size and wheeze; of these, three found an association between
restricted fetal growth and childhood wheeze6,7,40. Recently a fourth
study failed to find any such association41, although this study did not
assess equivalent dimensions at each gestation. Twin studies, which
study the effects of fetal growth restriction independently from
shared gestation, have demonstrated greater BHR to cold air chal-
lenge in the smaller twin of twin pairs discordant for birthweight13. In
the present study fetal growth was directly assessed by longitudinal
ultrasound of equivalent dimensions and confounding by neonatal
respiratory disease or treatment is unlikely as participants were term
subjects of normal birthweight.
Animal data suggest that adverse prenatal factors which are likely
to affect fetal growth are associated with increased BHR. For
example, increased BHR has been found in offspring ofmice exposed
to noise stress during pregnancy14. Similarly, we demonstrate that
isocaloric reduction of maternal protein intake in rats leads to BHR
in the offspring. BHR is thought to arise from an interplay between
airway remodelling, inflammatory processes and altered smooth
muscle18,42–44, however the exaggerated bronchial responsiveness in
our model was not associated with gross airway remodelling. This
suggests that BHR precedes bronchial remodelling, that remodelling
is not a prerequisite for BHR development and that developmental
factors may alter intrinsic smooth muscle function. Recently it has
been shown that chronic airway smooth muscle stimulation can lead
to muscle shortening and greater constriction to subsequent chal-
lenges45, while airway remodelling has been reported in response
to a methacholine challenge alone46. Taken together this suggests
repeated constrictions may predispose to remodelling in their own
right.
A possible explanation for the exaggerated constriction in the
present study is altered signalling in the bronchial smooth muscle
contractile apparatus. Maternal nutrient restriction in sheep leads to
excessive vasoconstriction in specific arterial beds of the off-
spring47–49 which is associated with an increase in myosin light chain
kinase mRNA levels47,48. An increase in contractile apparatus could
explain our results, but such increases would also have manifested in
an increased contraction to a depolarising K1 wash. This did not
occur, and enhanced constriction was only seen in response to ago-
nists, suggesting a role for RhoA and theCa21-independent pathway.
Rho A and its downstream target Rho-associated kinase enhance
constriction by inactivating myosin light chain phosphatase50.
Previous reports have demonstrated that inhibition of Rho assoc-
iated kinase leads to decreased bronchial contraction51, a finding
which we have confirmed in the present study. Crucially, however,
we have shown that the exaggerated response to CCh seen in the PR
group is no longer seen in the presence of the Rho kinase inhibitor,
suggesting a key role for Rho A in the BHR induced by maternal
protein restriction. At present it is unclear why increased bronchial
responsiveness was seen in the 75-day-old but not the 35-day-old
rats, although potentially an age-dependent change in Rho A or
Ca21-dependent signalling may explain this. Other studies have spe-
cifically implicated translocation of Rho A to the membrane in the
development of BHR18. The importance of this post-translational
Figure 4 | Volume factionation of lung components as percentage of
entire lung for both PR and C groups at 225 days of age (C5 6, PR5 6).
www.nature.com/scientificreports
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modification might also explain why we detected no difference
between experimental groups in RhoAmRNA. Further investigation
within this animal model would support exploration of the mechan-
isms believed to underlie increased BHR, whilst in vivo animalmodel
testing would confirm the relevance of the model to human disease.
In summary, in utero stress conferred by protein restriction during
pregnancy increases bronchial reactivity in rats and there are epide-
miological data that suggest a similar effect might exist in humans.
Taken together these findings suggest adverse in utero conditions are
associated with a specific impairment of respiratory development.
Methods
Ethics statement.All animal procedures carried out in this study were in accordance
with the regulations of the British Home Office Animals (Scientific Procedures) Act,
1986 (under licence number PPL 30/2884) and this study was approved by the local
ethical review committee. Animals were sacrificed by cervical dislocation. For human
participants written informed parental consent was obtained and ethical approval for
this and all other human aspects of the study was granted by the Southampton and
South West Hampshire Research Ethics Committee (276/97, 307/97, 089/99, 06/
Q1702/104).
Animal model.Virgin female Wistar rats (Harlan, UK) were mated with stud males.
After confirming conception mothers were fed either a control (C; 18% casein) or a
protein-restricted diet (PR; 9% casein)21. Diets were isocaloric and of comparable
vitamin and mineral content16. Mothers and pups were fed standard laboratory chow
postpartum.
Pups were weighed at 48 hours and litters culled to eight. Weaning was at 21 days.
At 35, 75 or 225 days of age male offspring were sacrificed and lung tissue harvested.
Assessment of bronchoconstriction. Lungs were excised and placed in 4uCphysiological
salt solution (PSS), (NaCl, 119; KCl, 4.7; CaCl2, 2.5; MgSO4, 1.17; NaHCO3, 25;
KH2PO4, 1.18; EDTA, 0.026; and D-glucose, 5.5 mM). Third generation bronchi
were dissected into 2 mm segments and mounted on a wire myograph (Danish Myo
Technology A/S, DK). Segments were maintained in 37uC PSS, gassed with 95% O2
and 5% CO2.
Segments were stretched to optimal resting tension (1.5 g) and allowed one hour
equilibration. Functional integrity was tested using 125 mMKPSS solution (PSS with
equimolar KCl for NaCl substitution). Cumulative concentration-response curves
were constructed for the acetylcholine mimetic, carbachol (Sigma-AldrichH) (CCh,
1 nM–10 mM) and the thromboxane mimetic, U46619 (Tocris Bioscience) (1 pM–
1 mM). In a subgroup, CCh responses were repeated in the presence of the Rho kinase
inhibitor Y27632 (Sigma-Aldrich; 10 mM).
Molecular biology. mRNA expression in isolated bronchi was determined using real
time PCR relative to b-actin (TaqMan, Applied Biosystems, Warrington, U.K.).
Primers and probes are given in Table S3.
Morphometry. Left lungs were formalin fixed for 24 hours and embedded in Paraffin
wax. An unbiased stereological analysis approach was employed22. Starting at a
random point a 5 um section was cut 500 mm intervals throughout the entire lung.
Sections were H&E stained, 30–70 photographs taken of each section and 1 in 10
analysed to determine the volume fraction of airway tissue, airway lumen, epithelium,
smooth muscle using a point counting system (Figure 4).
Human participants. Participants were mother-child pairs from the Southampton
Women’s Survey23. Six-year-old children were invited for respiratory follow-up; 246
underwent methacholine challenge (Figure 5). Seven children born , 35 weeks’
gestation were excluded to remove the effects of prematurity.
Fetal growth. Gestational age was determined from last menstrual period and early
ultrasound data. Fetal head and abdominal circumferences at 11, 19 and 34 weeks’
gestation were measured according to standardized landmarks using Acuson 128 XP,
Aspen and Sequoia ultrasound machines calibrated to 1540 m/s. Head and abdom-
inal circumferences and weight were measured at birth. Conditional velocities of
prenatal head and abdominal circumference growth were calculated, correcting for
age at measurement and regression to the mean24.
Bronchial hyperreactivity. Bronchial hyperreactivity was measured by bronchial
provocation challenge, according to ATS/ERS guidelines25. Incremental methacho-
line concentrations (0.06 mg/ml to 16 mg/ml) were delivered using a dosimeter
Table 1 | Linear regression for fetal and infant growth variables and BHR
Unadjusted analysis Adjusted analysis
Beta 95% CI P-value n Beta 95% CI P-value n
Birthweight 20.040 20.400 to 0.319 0.83 225 20.051 20.408 to 0.307 0.78 224
Head circumference at birth 20.001 20.362 to 0.359 0.99 225 20.017 20.376 to 0.341 0.92 224
Abdominal circumference at birth 0.108 20.261 to 0.478 0.56 225 0.134 20.239 to 0.506 0.48 221
Head circumference growth between 11
and 19 weeks’ gestation
20.152 20.678 to 0.374 0.57 114 20.224 20.726 to 0.279 0.38 113
Abdominal circumference growth between
11 and 19 weeks’ gestation
0.490 20.138 to 1.119 0.13 110 0.643 0.038 to 1.247 0.037 109
Head circumference growth between 19
and 34 weeks’ gestation
20.066 20.410 to 0.278 0.71 216 20.050 20.393 to 0.293 0.77 213
Abdominal circumference growth between
19 and 34 weeks’ gestation
0.131 20.199 to 0.461 0.43 224 0.246 20.095 to 0.584 0.15 221
Measurements of circumferential growth were calculated as the conditional change in the relevant circumference between either 11 and 19 or 19 and 34 weeks’ gestation conditional on either 11 or 19
week circumference respectively. Measurements were corrected for regression to the mean and exact age at measurement Not all women were scanned at each time point and positioning of the fetus
occasionally precluded some measurements. If identified as a likely confounder in the multivariate model, the following were adjusted for: maternal history of asthma, eczema, rhinitis or atopy; paternal
history of asthma, eczema or rhinitis; maternal age, body mass index, height, smoking in pregnancy, educational achievement and parity; child’s gender and parental social class.
Figure 5 | Follow-up within the Southampton Women’s Survey.
www.nature.com/scientificreports
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(Koko; PDS Instrumentation; Louisville, USA) and a compressed air driven nebulizer
(SidestreamH; Respironics, UK). Challenges were terminated following a 20% fall in
the FEV1 or, if this did not occur, following the 16 mg/ml dose. BHRwas expressed as
the inverse of the slope of the regression line through FEV1 drop and logged meth-
acholine concentration such that lower inverse log slope values indicate increased
BHR.
Log slope 5 100/[regression slope of FEV1 drop and log10(cumulative meth-
acholine dose) 1 10].
A constant removes negative values and an inverse transformation ensures the
variable is normally distributed26.
Statistical analysis. Animal data are mean 6 (S.E.M) and constrictor responses are
change in raw tension (g) or percentage KPSS-induced tone. Cumulative response
curves were analysed by fitting a four-parameter logistic equation using non-linear
regression to obtain pEC50 (effective concentration equal to 50% of maximum) and
maximal response which were compared by Student’s t test (Prism 5.0, GraphPAD
software Inc., San Diego, CA, U.S.A.). Significance was accepted if p , 0.05. The
investigator was blinded to dietary group. Lung structures were expressed as
percentage of total lung and compared using the Mann Whitney rank sum test.
Childhood BHR was expressed as the inverse slope of the regression line through
FEV1 fall and logged methacholine concentration, lower inverse log slope indicating
increased BHR26. Using this continuous outcome it was possible to use data from all
participants and to maximize power to assess the relationship between fetal growth
and BHRusing linear regression. The following potential confounders were identified
a priori: maternal age, body mass index, height, smoking in pregnancy, education,
parity, history of asthma, eczema, rhinitis or atopy; paternal history of asthma,
eczema or rhinitis; child’s gender and parental social class. A forward stepwise
multivariate model was built including all variables associated at p # 0.1. Size and
growth velocity measures were standardized and outcomes were expressed as change
in BHR per SD change in predictor. StataH11 (Stata Corp., College Station, TX) was
used for all analyses. An online supplement provides additional detail.
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